Agilent Technologies (A) Declined in Q1 Amid QIAGEN Acquisition Speculation

Article excerpt

Agilent Technologies saw its stock price fall during the first quarter as investors weighed the company's operational performance against swirling speculation about a potential acquisition of QIAGEN. The decline occurred despite ongoing business activity, with market watchers focused on whether Agilent would pursue the deal and at what valuation. The acquisition chatter added volatility to Agilent's trading, overshadowing the company's quarterly financial results and business fundamentals.